文献速递肿瘤 PET/CT

全身18F-FDG PET/CT快速2分钟采集对肝脏肿瘤的诊断性能:与传统PET/CT的比较

Diagnostic performance of total-body 18F-FDG PET/CT with fast 2-min acquisition for liver tumours: comparison with conventional PET/CT.
PubMed 文献 · Eur J Nucl Med Mol Imaging · 2022-03-28

本研究纳入156例肝脏肿瘤患者,其中78例接受全身PET/CT并以2分钟(G2)和15分钟(G15)采集重建,另78例接受传统uMI780 PET/CT(G780)。G15所见病灶在G2中均可见,仅G2漏诊3枚淋巴结,三组TNM分期无显著差异;G2肿瘤SUVmax和TLR与G15及G780相当,ROC分析示G2对肝癌检测有良好灵敏度。结论认为全身PET/CT 2分钟采集诊断性能与15分钟及传统PET/CT相似。

要点

  • G15所见病灶在G2中均可见,G2漏诊3枚淋巴结,三组TNM分期无显著差异。
  • 良恶性病灶中G2和G15的肝脏SUVmean均高于G780(均P<0.05)。
  • G2肿瘤SUVmax和TLR与G15及G780相当,ROC示G2对肝癌检测灵敏度良好。

核心结论

  • 全身PET/CT 2分钟采集(G2)在肝癌患者中的诊断性能与15分钟采集(G15)相当。
  • 全身PET/CT快速2分钟采集与传统PET/CT的诊断效能相似。

研究设计与样本

  • 本研究纳入156例肝脏肿瘤患者,其中78例接受全身PET/CT,原始数据按2分钟(G2)和15分钟(G15)采集时长重建。
  • 另78例肝脏病变对照患者接受传统uMI780 PET/CT(G780)。
  • 所有患者按TNM分期评估,以手术标本病理结果为金标准。

主要发现

  • G15所见病灶在G2中均可见,G2漏诊3枚淋巴结,但G2、G15和G780三组间TNM分期无显著差异。
  • 无论良性还是恶性病灶,G2和G15的肝脏SUVmean均高于G780(均P<0.05)。
  • 无论良性还是恶性病灶,G2的肿瘤SUVmax和TLR与G15及G780相当。
  • ROC曲线分析(SUVmax截断值4.34,TLR截断值1.34)示G2对肝癌检测也有良好灵敏度。

关键数值与推荐

  • ROC曲线分析采用SUVmax截断值4.34、TLR截断值1.34评估G2对肝癌的检测灵敏度。
  • 病灶可检测性分析以G15数据为参考。
  • 以手术标本病理结果为所有患者的金标准。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To comparatively evaluate the diagnostic performances of total-body 18F-fluorodeoxyglucose positron-emission tomography/computed tomography (18F-FDG PET/CT) with fast 2-min acquisition and conventional PET/CT in liver cancer patients. METHODS: This study included 156 patients with liver tumours. Seventy-eight patients underwent total-body PET/CT. PET raw data were reconstructed using acquisition durations of 2 min (G2) and 15 min (G15). Another 78 patients with liver lesions (control patients) underwent conventional uMI780 PET/CT (G780). All patients were evaluated based on TNM staging. The maximum tumour standardized uptake value (tumour SUVmax), mean normal liver SUV (SUVmean), and tumour SUVmax-to-liver SUVmean ratio (TLR) were determined for all patients. G15 data were used as the reference in the lesion detectability analysis. The diagnostic performances of PET/CT in terms of visual parameters and of PET in terms of semi-quantitative parameters such as SUVmax and TLR were evaluated. Receiver operating characteristics (ROC) curve analysis of SUVmax and TLR at G2 was performed. Pathologic findings of surgical specimens served as the gold standard for all patients. RESULTS: The lesions found in G15 were also noted in G2; three lymph nodes were missed in G2. However, no significant difference was found in the TNM stage among G2, G15, and G780. For benign and malignant lesions, the liver SUVmean in G2 and G15 was higher than that in G780 (all P < 0.05). The tumour SUVmax and TLR in G2 were equivalent to those in G15 and G780 regardless of whether the lesions were benign or malignant. ROC curve analysis (SUVmax cutoff: 4.34, TLR cutoff: 1.34) demonstrated that G2 also had good sensitivity in detecting liver cancer. CONCLUSION: The diagnostic performance of total-body PET/CT in G2 was comparable to that in G15 among liver cancer patients. Further, the diagnostic efficiency of total-body PET/CT imaging with fast 2-min acquisition and conventional PET/CT was similar.

来源:Eur J Nucl Med Mol Imaging,查看原文。版权归原作者所有。

引用

  1. Hu Y, Liu G, Yu H, et al. Diagnostic performance of total-body 18F-FDG PET/CT with fast 2-min acquisition for liver tumours: comparison with conventional PET/CT. Eur J Nucl Med Mol Imaging. 2022. PMID: 35344063. doi:10.1007/s00259-022-05772-2

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。